Invention Grant
- Patent Title: N-containing heterocyclic compounds
- Patent Title (中): 含氮杂环化合物
-
Application No.: US13706293Application Date: 2012-12-05
-
Publication No.: US08765755B2Publication Date: 2014-07-01
- Inventor: David Gerard Bourke , Christopher John Burns , Anthony Nicholas Cuzzupe , John Thomas Feutrill , Marcel Robert Kling , Tracy Leah Nero
- Applicant: YM Biosciences Australia Pty Ltd
- Applicant Address: AU Melbourne
- Assignee: YM Biosciences Australia Pty Ltd.
- Current Assignee: YM Biosciences Australia Pty Ltd.
- Current Assignee Address: AU Melbourne
- Agency: Gilead Sciences, Inc.
- Agent Yu-Ming Dammann
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D495/04
Abstract:
The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
Public/Granted literature
- US20130090336A1 N-CONTAINING HETEROCYCLIC COMPOUNDS Public/Granted day:2013-04-11
Information query
